Urogenital atrophy.
The major cause of urogenital atrophy in menopausal women is estrogen loss. The symptoms are usually progressive in nature and deteriorate with time from the menopausal transition. The most prevalent urogenital symptoms are vaginal dryness, vaginal irritation and itching. The classical changes in an atrophic vulva include loss of labial and vulvar fullness, with narrowing of the introitus and inflamed mucosal surfaces. Dyspareunia and vaginal bleeding from fragile atrophic skin are common problems. Other urogenital complaints include frequency, nocturia, urgency, incontinence and urinary tract infections. Atrophic changes of the vulva, vagina and lower urinary tract can have a large impact on the quality of life of the menopausal woman. However, hormonal and non-hormonal treatments can provide patients with the solution to regain previous level of function. Therefore, clinicians should sensitively question and examine menopausal women, in order to correctly identify the pattern of changes in urogenital atrophy and manage them appropriately.
Calleja-Agius
J
J
Department of Obstetrics and Gynaecology, Mater Dei Hospital, Malta.
Brincat
M P
MP
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001284:Atrophy; D003872:Dermatitis / Q000209:etiology; D004414:Dyspareunia / Q000209:etiology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008593:Menopause / Q000502:physiology*; D008875:Middle Aged; D011537:Pruritus / Q000209:etiology; D020018:Sexual Dysfunctions, Psychological / Q000209:etiology; D014552:Urinary Tract Infections / Q000209:etiology; D014566:Urogenital System / Q000473:pathology*; D014623:Vaginal Diseases / Q000209:etiology / Q000503:physiopathology; D014844:Vulva / Q000473:pathology; D014845:Vulvar Diseases / Q000209:etiology / Q000473:pathology